The neurological sequelae of pandemics and epidemics Fernanda ValerioDaniel P. WhitehouseVirginia F. J. Newcombe Review Open access 26 October 2020 Pages: 2629 - 2655
Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature Federico CagnazzoCaroline ArquizanVincent Costalat Review 30 October 2020 Pages: 2656 - 2665
COVID-19 in Parkinson’s disease: what holds the key? R. Sainz-AmoB. Baena-ÁlvarezA. Alonso-Cánovas Original Communication 24 October 2020 Pages: 2666 - 2670
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy Lorenzo MuccioliUmberto PensatoFrancesca Bisulli Original Communication Open access 08 October 2020 Pages: 2671 - 2675
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses François LersyThibault WillaumeStéphane Kremer Original Communication 21 November 2020 Pages: 2676 - 2684
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19 Edward NeedhamVirginia NewcombeStephen Sawcer Original Communication Open access 26 November 2020 Pages: 2685 - 2689
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review Shitiz SriwastavaMedha TandonShumaila Sultan Short Commentary 12 October 2020 Pages: 2690 - 2696
COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience Paolo PreziosaMaria A. RoccaMassimo Filippi Letter to the Editors 20 November 2020 Pages: 2697 - 2699
Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up Julia V. WanschitzManuela KamlRonny Beer Letter to the Editors 20 November 2020 Pages: 2700 - 2702
Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis Shengri CongChunchen XiangShuyan Cong Review 11 March 2020 Pages: 2703 - 2712
Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies Yu GuoFeng-Tao LiuJin-Tai Yu Review 12 March 2020 Pages: 2713 - 2722
Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature Angelos SharobeamBrett JonesChristian J. Lueck Review 21 March 2020 Pages: 2723 - 2734
Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience—a European perspective Manuel ToledoBarbara MostacciBettina Schmitz Review 01 April 2020 Pages: 2735 - 2748
Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis Alhassane DialloHeike JacobiThomas Klockgether Review 07 April 2020 Pages: 2749 - 2756
Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features Lisha TangQianyi HuangXiangqi Tang Review 07 April 2020 Pages: 2757 - 2768
Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis Lucy L. GibsonAnna McKeeverThomas A. Pollak Review Open access 18 April 2020 Pages: 2769 - 2779
Heritable and non-heritable uncommon causes of stroke A. BersanoM. KraemerH. S. Markus Review 21 April 2020 Pages: 2780 - 2807
Correction to: Heritable and non-heritable uncommon causes of stroke A. BersanoM. KraemerH. S. Markus Correction 18 June 2020 Pages: 2808 - 2809
Early recurrent ischemic events after mechanical thrombectomy: effect of post-treatment intracranial hemorrhage Junpei KogeKanta TanakaKazunori Toyoda Original Communication 16 February 2021 Pages: 2810 - 2820
Long term follow-up in advanced Parkinson’s disease treated with DBS of the subthalamic nucleus Maria Antonietta VolontéGiacomo ClarizioMassimo Filippi Original Communication 17 February 2021 Pages: 2821 - 2830
Effect of transcranial direct current stimulation on post-stroke fatigue William De DonckerSasha OndobakaAnnapoorna Kuppuswamy Original Communication Open access 17 February 2021 Pages: 2831 - 2842
Deficient visuomotor hand coordination in normal pressure hydrocephalus Hannah KösterKatharina Müller-SchmitzRüdiger J. Seitz Original Communication Open access 17 February 2021 Pages: 2843 - 2850
Central positional nystagmus in inferior cerebellar peduncle lesions: a case series Sun-Uk LeeHyo-Jung KimJi-Soo Kim Original Communication 18 February 2021 Pages: 2851 - 2857
First measured retinal nerve fiber layer thickness in RRMS can be used as a biomarker for the course of the disease: threshold value discussions Vedat CilingirMuhammed Batur Original Communication 19 February 2021 Pages: 2858 - 2865
Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology) Veronica VillaniElena AnghileriAndrea Pace Original Communication 20 February 2021 Pages: 2866 - 2875
Heterogeneity of behavioural and language deficits in FTD–MND Zhe LongMuireann IrishJames R. Burrell Original Communication 20 February 2021 Pages: 2876 - 2889
CSF interleukin 6 is a useful marker to distinguish pseudotumoral CNS inflammatory diseases from primary CNS lymphoma Aurelian UngureanuMagali Le Garff-TavernierGuido Ahle Original Communication 20 February 2021 Pages: 2890 - 2894
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy Rosa CorteseLuca ProsperiniCarla Tortorella Original Communication 20 February 2021 Pages: 2895 - 2899
Event-related potentials using the auditory novel paradigm in patients with myotonic dystrophy Shugo SuwazonoHiroshi AraoShino Maedou Original Communication 20 February 2021 Pages: 2900 - 2907
CIDP associated with Sjögren’s syndrome Tabea SeeligerStefan GingeleThomas Skripuletz Original Communication 21 February 2021 Pages: 2908 - 2912
Evolution of caloric responses during and between the attacks of Meniere’s disease Sun-Uk LeeHyo-Jung KimJi-Soo Kim Original Communication 21 February 2021 Pages: 2913 - 2921
Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study Sebastiano BucelloPietro AnnovazziLuca Prosperini Original Communication 22 February 2021 Pages: 2922 - 2932
Phenotypic and molecular diversities of spinocerebellar ataxia type 2 in Japan Rino InadaMakito HiranoSusumu Kusunoki Original Communication 24 February 2021 Pages: 2933 - 2942
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease Stephan WenningerKristina GutschmidtBenedikt Schoser Original Communication Open access 24 February 2021 Pages: 2943 - 2950
Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study Chung-Yao ChenChia-Ling ChenChung-Chieh Yu Original Communication 24 February 2021 Pages: 2951 - 2960
Contribution of neuropsychiatric symptoms in Parkinson’s disease to different domains of caregiver burden L. M. ChahineR. FeldmanC. Marras Original Communication Open access 25 February 2021 Pages: 2961 - 2972
Time-trend evolution and determinants of sex ratio in Amyotrophic Lateral Sclerosis: a dose–response meta-analysis Andrea FontanaBenoit MarinMassimilano Copetti Original Communication 25 February 2021 Pages: 2973 - 2984
Quantitative analysis of dysautonomia in patients with autonomic dysreflexia Nora Cívicos SánchezMarian AceraJuan Carlos Gómez Esteban Original Communication 25 February 2021 Pages: 2985 - 2994
Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra Joseph R. BergerClyde MarkowitzZissimos Mourelatos Original Communication 26 February 2021 Pages: 2995 - 2999
Recurrent seizures of autoimmune origin: emerging phenotypes Mathilde GoudotSolène FrismandLouise Tyvaert Original Communication 27 February 2021 Pages: 3000 - 3010
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up Laura FiondaAntonella Di PasqualeGiovanni Antonini Original Communication 27 February 2021 Pages: 3011 - 3019
Predictors and outcomes of ischemic stroke in reversible cerebral vasoconstriction syndrome Aayushi GargMatthew StarrSantiago Ortega-Gutierrez Original Communication 01 March 2021 Pages: 3020 - 3025
An overview of viral infections of the nervous system in the immunosuppressed Peter G. E. Kennedy Neurological Update Open access 13 October 2020 Pages: 3026 - 3030
DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder Aiysha ChaudhryAlkyoni Anthanasiou-FragkouliHenry Houlden Neurological Update Open access 26 October 2020 Pages: 3031 - 3041
Correction to: DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder Aiysha ChaudhryAlkyoni Athanasiou-FragkouliHenry Houlden Correction Open access 21 June 2021 Pages: 3042 - 3042
Contribution of multi-modal imaging to our understanding of dystonia pathogenesis Claire MacIverKathryn Peall Journal Club Open access 14 July 2021 Pages: 3043 - 3045
Janina Hurynowicz (1894–1967) Anita MagowskaPiotr Skalski Pioneers in Neurology Open access 14 October 2020 Pages: 3046 - 3048
Adolph Seeligmüller (1837–1912) Carolin ArendtStephan Zierz Pioneers in Neurology Open access 21 October 2020 Pages: 3049 - 3051
Hans Joachim Scherer (1906–1945) José Berciano Pioneers in Neurology 11 November 2020 Pages: 3052 - 3053
Ludwig Horn (1897–1935) Lazaros C. Triarhou Pioneers in Neurology 13 November 2020 Pages: 3054 - 3055